EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GPER activation attenuates cardiac dysfunction by upregulating the SIRT1/3-AMPK-UCP2 pathway in postmenopausal diabetic rats

Hossein Azizian, Zeinab Farhadi, Michael Bader, Jalil Alizadeh Ghalenoei iD, Mohammad Amin Ghafari, Shokoufeh Mahmoodzadeh iD

PLOS ONE · 22.12.2023 · 18 (12) · e0293630

DOI: 10.1371/journal.pone.0293630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 22.12.2023. Verfasst von Hossein Azizian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Yazd Neuroendocrine Research Center, School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Ventricular Dysfunction, Left. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shahid Sadoughi University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Postmenopausal diabetic women are at higher risk to develop cardiovascular diseases (CVD) compared with nondiabetic women. Alterations in cardiac cellular metabolism caused by changes in sirtuins are one of the main causes of CVD in postmenopausal diabetic women. Several studies have demonstrated the beneficial actions of the G protein-coupled estrogen receptor (GPER) in postmenopausal diabetic CVD. However, the molecular mechanisms by which GPER has a cardioprotective effect are still not well understood. In this study, we used an ovariectomized (OVX) type-two diabetic (T2D) rat model induced by high-fat diet/streptozotocin to investigate the effect of G-1 (GPER-agonist) on sirtuins, and their downstream pathways involved in regulation of cardiac metabolism and function. Animals were divided into five groups: Sham-Control, T2D, OVX+T2D, OVX+T2D+Vehicle, and OVX+T2D+G-1. G-1 was administrated for six weeks. At the end, hemodynamic factors were measured, and protein levels of sirtuins, AMP-activated protein kinase (AMPK), and uncoupling protein 2 (UCP2) were determined by Western blot analysis. In addition, cardiac levels of oxidative stress biomarkers were measured. The findings showed that T2D led to left ventricular dysfunction and signs of oxidative stress in the myocardium, which were accompanied by decreased protein levels of Sirt1/2/3/6, p-AMPK, and UCP2 in the heart. Moreover, the induction of the menopausal state exacerbated these changes. In contrast, treatment with G-1 ameliorated the hemodynamic changes associated with ovariectomy by increasing Sirt1/3, p-AMPK, UCP2, and improving oxidative status. The results provide evidence of the cardioprotective effects of GPER operating through Sirt1/3, p-AMPK, and UCP2, thereby improving cardiac function. Our results suggest that increasing Sirt1/3 levels may offer new therapeutic approaches for postmenopausal diabetic CVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Ventricular Dysfunction, LeftAnimalsFemaleRatsAMP-Activated Protein KinasesEstrogensPostmenopauseReceptors, G-Protein-CoupledSirtuin 1Uncoupling Protein 2Sirtuins

Substanzen

AMP-Activated Protein KinasesEstrogensReceptors, G-Protein-CoupledSirtuin 1Uncoupling Protein 2Gper1 protein, ratUcp2 protein, ratSirt1 protein, ratSIRT3 protein, ratSirtuins

Autor:innen und Institutionen

  • Yazd Neuroendocrine Research Center, School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran.
  • Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
  • DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.
  • Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • University of Lübeck, Institute for Biology, Lübeck, Germany.

ORCID-Profile: Jalil Alizadeh Ghalenoei, Shokoufeh Mahmoodzadeh

Förderung

  • Shahid Sadoughi University of Medical Sciences

Zitieren

APA

Azizian, H., Farhadi, Z., Bader, M., Alizadeh Ghalenoei, J., Ghafari, M. A., & Mahmoodzadeh, S. (2023). GPER activation attenuates cardiac dysfunction by upregulating the SIRT1/3-AMPK-UCP2 pathway in postmenopausal diabetic rats. PLOS ONE, 18(12), e0293630. https://doi.org/10.1371/journal.pone.0293630

Vancouver

Azizian H, Farhadi Z, Bader M, Alizadeh Ghalenoei J, Ghafari MA, Mahmoodzadeh S. GPER activation attenuates cardiac dysfunction by upregulating the SIRT1/3-AMPK-UCP2 pathway in postmenopausal diabetic rats. PLOS ONE. 2023;18(12):e0293630. doi:10.1371/journal.pone.0293630

BibTeX
@article{Azizian2023,
  author = {Azizian, Hossein and Farhadi, Zeinab and Bader, Michael and Alizadeh Ghalenoei, Jalil and Ghafari, Mohammad Amin and Mahmoodzadeh, Shokoufeh},
  title = {GPER activation attenuates cardiac dysfunction by upregulating the SIRT1/3-AMPK-UCP2 pathway in postmenopausal diabetic rats},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {12},
  pages = {e0293630},
  doi = {10.1371/journal.pone.0293630}
}
Kostenlos starten →